ArticleTranslational oncology2017

Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease.

Jyothi S Prabhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.